Peri-onset non-steroidal anti-inflammatory drugs use and organ failure in acute pancreatitis: A multicenter retrospective analysis

Hsing-Chien Wu,Kuo-Liong Chien,Jing-Rong Jhuang,Yen-Yun Yang,Wei-Chih Liao
DOI: https://doi.org/10.1016/j.dld.2023.12.010
IF: 5.165
2024-01-17
Digestive and Liver Disease
Abstract:Background Organ failure (OF) of acute pancreatitis (AP) significantly contributes to AP-related mortality. Non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with reduced complications of AP. Aims We aimed to investigate whether NSAIDs ameliorates SIRS and OF in patients with AP. Methods Eligible patients with AP were retrospectively identified in 4 hospitals between January 2015 and December 2018. Associations between peri-onset NSAIDs use (day -3 to day 3) and OF, persistent OF (POF), and SIRS within the first week were analyzed. Propensity score-matched (PSM) analysis and inverse probability of treatment-weighted (IPTW) analysis were used to estimate risk ratios. Results Among 1,528 patients with AP (97 [6.3%] with NSAIDs use), 242 (15.8%) developed organ failure, 89 (5.8%) progressed to POF, and 27 (1.8%) died within 3 months. PSM analysis showed no association between peri-onset NSAIDs and OF (risk ratio [RR], 1.00; 95% confidence interval [CI], 0.46 to 2.15) and POF (RR, 0.80; 95% CI, 0.21 to 2.98). IPTW analysis yielded similar results. Patients with and without peri-onset NSAIDs use were comparable with respect to OF, POF, and SIRS across subgroups defined by COX-2 selectivity and dose. Conclusion Peri-onset NSAIDs use was not significantly associated with reduced OF.
gastroenterology & hepatology
What problem does this paper attempt to address?